Share on StockTwits

Research analysts at Raymond James assumed coverage on shares of MedAssets (NASDAQ:MDAS) in a report released on Tuesday, Stock Ratings News reports. The firm set an “outperform” rating and a $27.00 price target on the stock. Raymond James’ price target indicates a potential upside of 16.03% from the stock’s previous close.

MedAssets (NASDAQ:MDAS) opened at 23.27 on Tuesday. MedAssets has a one year low of $16.31 and a one year high of $26.58. The stock has a 50-day moving average of $24.39 and a 200-day moving average of $22.66. The company has a market cap of $1.437 billion and a P/E ratio of 51.71.

MedAssets (NASDAQ:MDAS) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.30 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.28 by $0.02. The company had revenue of $170.50 million for the quarter, compared to the consensus estimate of $165.64 million. During the same quarter last year, the company posted $0.27 earnings per share. MedAssets’s revenue was up 4.1% compared to the same quarter last year. Analysts expect that MedAssets will post $1.39 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at SunTrust initiated coverage on shares of MedAssets in a research note on Wednesday, April 9th. They set a “neutral” rating and a $25.00 price target on the stock. Separately, analysts at RBC Capital raised their price target on shares of MedAssets from $21.00 to $25.00 in a research note on Monday, April 7th. Finally, analysts at Barclays initiated coverage on shares of MedAssets in a research note on Wednesday, March 5th. They set an “equal weight” rating and a $23.00 price target on the stock. Nine equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $25.79.

MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.